Anna L. Di Stefano

Suresnes, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications

Beyond the Brain: Circulating Tumor Cells as a Tool for Diagnosis and Monitoring.

Beyond the Brain: Circulating Tumor Cells as a Tool for Diagnosis and Monitoring.

Journal: JCO precision oncology
Published: July 23, 2026

BIRC3/CAV1 co-expression drives GBM aggressiveness as a prognostic signature and therapeutic vulnerability.

BIRC3/CAV1 co-expression drives GBM aggressiveness as a prognostic signature and therapeutic vulnerability.

Journal: Cell death discovery
Published: November 26, 2025

Prognostic impact of circulating vitamin D and genetic variants in the vitamin D pathway in glioblastoma.

Prognostic impact of circulating vitamin D and genetic variants in the vitamin D pathway in glioblastoma.

Journal: Neuro-oncology advances
Published: October 17, 2025

Advances in the management of patients with IDH-mutant glioma.

Advances in the management of patients with IDH-mutant glioma.

Journal: The oncologist
Published: June 20, 2025

Rebound Growth Following Temporary Discontinuation of BRAFi and MEKi in a Patient With Multifocal BRAFV600E-Mutant Primary Brain Tumor.

Rebound Growth Following Temporary Discontinuation of BRAFi and MEKi in a Patient With Multifocal BRAFV600E-Mutant Primary Brain Tumor.

Journal: Neurology
Published: May 01, 2025

CellHit: a web server to predict and analyze cancer patients' drug responsiveness.

CellHit: a web server to predict and analyze cancer patients' drug responsiveness.

Journal: Nucleic acids research
Published: March 24, 2025

Resistance of recurrent epidermal growth factor receptor-altered glioblastoma to anti-epidermal growth factor receptor targeted therapy with osimertinib.

Resistance of recurrent epidermal growth factor receptor-altered glioblastoma to anti-epidermal growth factor receptor targeted therapy with osimertinib.

Journal: The oncologist
Published: February 19, 2025

Rebound Growth Following Temporary Discontinuation of BRAFi and MEKi in a Patient With Multifocal BRAFV600E-Mutant Primary Brain Tumor.

Rebound Growth Following Temporary Discontinuation of BRAFi and MEKi in a Patient With Multifocal BRAFV600E-Mutant Primary Brain Tumor.

Journal: Neurology
Published: January 17, 2025

Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study.

Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study.

Journal: Neuro-oncology
Published: December 12, 2024

Targeting Mitochondria in Glioma: New Hopes for a Cure.

Targeting Mitochondria in Glioma: New Hopes for a Cure.

Journal: Biomedicines
Published: November 03, 2024

Acquired genetic and cell-state changes in IDH-mutant glioma progression.

Acquired genetic and cell-state changes in IDH-mutant glioma progression.

Journal: Nature
Published: October 05, 2024

Exploring Extracellular Vesicle Surface Protein Markers Produced by Glioblastoma Tumors: A Characterization Study Using In Vitro 3D Patient-Derived Cultures.

Exploring Extracellular Vesicle Surface Protein Markers Produced by Glioblastoma Tumors: A Characterization Study Using In Vitro 3D Patient-Derived Cultures.

Journal: Cancers
Published: September 28, 2024
Showing 1-12 of 74

Last Updated: 09/26/2026